The Therapeutic Goods Administration (TGA) of Australia is reviewing the potential for low-risk OTC products that have “a long history of use at particular ingredient levels and dosage forms” to become eligible as ‘Listed’ medicines. TGA believes reducing the regulatory burden of bringing these types of products to market may reduce their cost to consumers.
[/membership]
